PubRank

Christine L Mummery

Author PubWeight™ 135.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007 9.36
2 MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007 6.41
3 A promoter-level mammalian expression atlas. Nature 2014 6.25
4 Stem-cell-based therapy and lessons from the heart. Nature 2008 4.54
5 Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells 2008 3.33
6 Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 2006 3.24
7 Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007 3.04
8 Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 2009 3.03
9 Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 2010 2.88
10 Ethics. The ISSCR guidelines for human embryonic stem cell research. Science 2007 2.62
11 Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol 2012 2.50
12 Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 2008 2.31
13 NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods 2011 2.29
14 Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 2009 2.13
15 Isl1Cre reveals a common Bmp pathway in heart and limb development. Development 2006 2.04
16 A quest for human and mouse embryonic stem cell-specific proteins. Mol Cell Proteomics 2006 2.04
17 TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 2008 1.98
18 Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Hum Mol Genet 2007 1.68
19 An experimental correction for arginine-to-proline conversion artifacts in SILAC-based quantitative proteomics. Nat Methods 2007 1.59
20 Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. Dev Cell 2012 1.53
21 Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 2012 1.53
22 Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res 2009 1.52
23 Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 2004 1.40
24 BMP signaling mediated by ALK2 in the visceral endoderm is necessary for the generation of primordial germ cells in the mouse embryo. Genes Dev 2004 1.40
25 Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification. Nat Protoc 2008 1.34
26 Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A. PLoS One 2011 1.33
27 Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat Protoc 2007 1.31
28 Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice. J Cell Sci 2007 1.31
29 Improved genetic manipulation of human embryonic stem cells. Nat Methods 2008 1.29
30 Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J 2013 1.24
31 Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 2006 1.23
32 Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. J Proteome Res 2008 1.22
33 Identification of novel regulators associated with early-phase osteoblast differentiation. J Bone Miner Res 2004 1.20
34 Comprehensive microarray analysis of bone morphogenetic protein 2-induced osteoblast differentiation resulting in the identification of novel markers for bone development. J Bone Miner Res 2002 1.19
35 Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. Trends Mol Med 2011 1.18
36 Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts. Bone 2005 1.17
37 Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol Sci 2009 1.16
38 Real time monitoring of BMP Smads transcriptional activity during mouse development. Genesis 2008 1.16
39 Conversion of mature human β-cells into glucagon-producing α-cells. Diabetes 2013 1.16
40 Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Front Physiol 2012 1.15
41 Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies. Reprod Toxicol 2005 1.14
42 Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins. J Cell Sci 2004 1.11
43 Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models. Biochem J 2011 1.11
44 Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J Proteome Res 2010 1.11
45 From stealing fire to cellular reprogramming: a scientific history leading to the 2012 Nobel Prize. Stem Cell Reports 2013 1.10
46 Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. Cardiovasc Res 2003 1.10
47 Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 2009 1.09
48 Transplantation of cells for cardiac repair. J Am Coll Cardiol 2003 1.09
49 Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction. Dev Dyn 2004 1.08
50 Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device. Lab Chip 2013 1.08
51 Patterning the heart, a template for human cardiomyocyte development. Dev Dyn 2006 1.02
52 Cardiomyocytes derived from stem cells. Ann Med 2005 1.02
53 Generation of a floxed allele of the mouse Endoglin gene. Genesis 2007 1.02
54 Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia. Trends Cardiovasc Med 2008 1.01
55 Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts. Arterioscler Thromb Vasc Biol 2013 1.00
56 Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size. Stem Cell Res 2009 1.00
57 Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes. Cell Mol Life Sci 2009 1.00
58 Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts. PLoS One 2011 0.98
59 Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem? Stem Cells Dev 2015 0.98
60 A P19Cl6 GFP reporter line to quantify cardiomyocyte differentiation of stem cells. Int J Dev Biol 2004 0.97
61 Receptor protein tyrosine phosphatase mu expression as a marker for endothelial cell heterogeneity; analysis of RPTPmu gene expression using LacZ knock-in mice. Int J Dev Biol 2003 0.97
62 Distribution of phosphorylated Smad2 identifies target tissues of TGF beta ligands in mouse development. Gene Expr Patterns 2003 0.94
63 Feeder-free monolayer cultures of human embryonic stem cells express an epithelial plasma membrane protein profile. Stem Cells 2008 0.93
64 Cardiology: solace for the broken-hearted? Nature 2005 0.93
65 Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells 2006 0.92
66 Embryonic stem cell proteomics. Expert Rev Proteomics 2006 0.92
67 Dual reporter MESP1 mCherry/w-NKX2-5 eGFP/w hESCs enable studying early human cardiac differentiation. Stem Cells 2015 0.91
68 Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes. J Cell Mol Med 2014 0.90
69 Proteomics and human embryonic stem cells. Stem Cell Res 2008 0.90
70 A practical guide for the identification of membrane and plasma membrane proteins in human embryonic stem cells and human embryonal carcinoma cells. Proteomics 2008 0.89
71 Smooth muscle diversity from human pluripotent cells. Nat Biotechnol 2012 0.89
72 Impaired recruitment of HHT-1 mononuclear cells to the ischaemic heart is due to an altered CXCR4/CD26 balance. Cardiovasc Res 2009 0.88
73 Model systems for cardiovascular regenerative biology. Cold Spring Harb Perspect Med 2013 0.87
74 Direct visualization of Smad1/5/8-mediated transcriptional activity identifies podocytes and collecting ducts as major targets of BMP signalling in healthy and diseased kidneys. J Pathol 2011 0.87
75 Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models. Expert Opin Drug Saf 2011 0.85
76 SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development. Dev Dyn 2007 0.84
77 Altered primordial germ cell migration in the absence of transforming growth factor beta signaling via ALK5. Dev Biol 2005 0.84
78 Visceral endoderm induces specification of cardiomyocytes in mice. Stem Cell Res 2009 0.83
79 Poor vessel formation in embryos from knock-in mice expressing ALK5 with L45 loop mutation defective in Smad activation. Lab Invest 2009 0.83
80 Human stem cell models for predictive cardiac safety pharmacology. Stem Cell Res 2010 0.83
81 Knock-in of integrin beta 1D affects primary but not secondary myogenesis in mice. Development 2003 0.82
82 Cardiomyocyte reprogramming and the new age of cellular alchemy. J Mol Cell Cardiol 2012 0.81
83 Human stem cells shape the future of cardiac regeneration research. Int J Cardiol 2004 0.80
84 Tbx6 is a determinant of cardiac and neural cell fate decisions in multipotent P19CL6 cells. Differentiation 2012 0.79
85 Genetic manipulation of human embryonic stem cells in serum and feeder-free media. Methods Mol Biol 2010 0.79
86 Assessment of functional competence of endothelial cells from human pluripotent stem cells in zebrafish embryos. Methods Mol Biol 2014 0.78
87 Direct cardiomyocyte reprogramming: a new direction for cardiovascular regenerative medicine. Cold Spring Harb Perspect Med 2013 0.77
88 Cell replacement therapies: is it time to reprogram? Hum Gene Ther 2014 0.77
89 Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system. Differentiation 2013 0.77
90 On the streets of San Francisco: highlights from the ISSCR Annual Meeting 2010. Cell Stem Cell 2010 0.75
91 Stem cells: Cloning human embryos. Nature 2013 0.75
92 Spotlight on stem cells--makes old hearts fresh. Cardiovasc Res 2003 0.75